Hospitalisation costs of metastatic melanoma in France; the MELISSA study (MELanoma In hoSpital coSts Assessment)
Crossref DOI link: https://doi.org/10.1186/s12913-017-2472-0
Published Online: 2017-08-08
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fernandes, Jérôme
Bregman, Bruno
Combemale, Patrick
Amaz, Camille
de Léotoing, Lucie
Vainchtock, Alexandre
Gaudin, Anne-Françoise
Funding for this research was provided by:
Bristol-Myers Squibb